Searched for
BHARAT SERUMS TAKEOVER
M&A activity set to remain strong in 2026 after $104 billion domestic consolidation in 2025India's dealmaking activity is poised for a strong 2026, building on a robust 2025. Domestic consolidation and outbound deals surged this y...- Mankind can clear debt taken for BSV buy in 3 years: MD Rajeev JunejaMankind Pharma aims to clear its ₹13,630-crore debt from acquiring Bharat Serums and Vaccines within three years, according to MD Rajeev Ju...
- Mankind Pharma is frontrunner in Bharat Serums bidMankind Pharma is in talks to acquire Bharat Serums & Vaccines Ltd., a biopharmaceutical company with brands like Manforce Condoms and Preg...
- Advent looking to deploy $5 to $10 billion in India over the next five yearsAdvent International believes that Indian valuations are not a barrier to making deals, as they are relative to growth opportunities and ri...
- View: Eminent rise of M&AsDespite the global challenges of high interest rates and geopolitical uncertainties, the economy remains resilient, buoyed by rising domest...
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Poonawalla Finance offers special loans to company secretariesThe non-bank entity is a part of Cyrus Poonawalla group, which owns Serum institute, engaged in developing vaccines for the coronavirus.
Load More